Issue 5, 2020

Synthetic approaches towards avibactam and other diazabicyclooctane β-lactamase inhibitors

Abstract

Avibactam is a non β-lactam β-lactamase inhibitor that has recently been approved in association with a β-lactam antibiotic for the treatment of severe infections caused by otherwise resistant bacteria. Its therapeutic success encouraged the development of many congeners based on its particular diazabicyclooctane scaffold. This review presents a detailed overview of the synthetic strategies that have been implemented to acces these complex bicyclic compounds with a particular focus on those that are currently on the market or in clinical trials.

Graphical abstract: Synthetic approaches towards avibactam and other diazabicyclooctane β-lactamase inhibitors

Article information

Article type
Review Article
Submitted
06 déc. 2019
Accepted
13 janv. 2020
First published
13 janv. 2020

Org. Biomol. Chem., 2020,18, 830-844

Synthetic approaches towards avibactam and other diazabicyclooctane β-lactamase inhibitors

L. Peilleron and K. Cariou, Org. Biomol. Chem., 2020, 18, 830 DOI: 10.1039/C9OB02605C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements